Article Index
Biotech

GILD Stock Is Like a Falling Knife Gilead Sciences, Inc. (NASDAQ:GILD) reported earnings after the close of business on February 7, 2017 and even though the company managed to beat both on the top and bottom lines, GILD stock has been trading sharply lower by 9.53%. The forward…

CELG Stock: Bullish on All Fronts I have had my eye on Celgene Corporation (NASDAQ:CELG) stock and the price action on the CELG stock chart continues to suggest that something is brewing. The Celgene stock price action has been bullish and I have to assume that the flavor…

BMY Stock: More Pain Bristol-Myers Squibb Co (NYSE:BMY) stock was pounded with selling pressure after a news release hit the news wires with the announcement that the company will no longer seek accelerated approval of its immunotherapy cancer drug “Opdivo." By the time the closing bell rang on Friday,…

Why APRI Stock Is Flying Right Now Apricus Biosciences Inc (NASDAQ:APRI) saw its APRI stock soar over 140% by early afternoon trading on Wednesday as Mexico gave market approval for an erectile dysfunction (ED) treatment. Move over, "Cialis," there's a new treatment in town for ED. Or, at…

Validation and a Couple Wins for VRX Stock  Valeant Pharmaceuticals Intl Inc (NYSE:VRX) must be feeling some measure of validation as the U.S. Securities and Exchange Commission (SEC) has levied a $15.0 million fine at Allergan plc (NYSE:AGN) for failing to disclose news of friendlier bids during a hostile takeover…

Biotech Industry: Not a Trump Stock  President-elect Donald Trump had some harsh words for the biotech industry at his first press conference since his election, affecting both health and biotech shares. This will undoubtedly sour Trump biotech relations, as well as clearly define the industry as being a…

Valeant's Sell-Offs to L'Oreal and Sanpower Boosted VRX Stock Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is starting 2017 off on a good note, with VRX stock up over six percent by early afternoon trading on Tuesday. The boost came as a result of several big sales that the company was able to make,…

ETRM Stock Goes Wild EnteroMedics Inc (NASDAQ:ETRM) saw its stock climb by 106% on Thursday after the company's treatment for obesity, metabolic diseases, and other gastrointestinal disorders was implanted at two additional institutes, creating a surge in ETRM stock. Called "vBloc" neurometabolic therapy, EnteroMedics flagship treatment's expansion announced on…

REGN Stock: This Bear Is Fierce 2016 was a disappointing year for REGN stock, and 2017 is not faring any better as it is off to a poor start. On Thursday January 5, a U.S Federal judge ruled that Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR)(NYSE:SNY) have infringed on…

BIIB Stock: Awaiting the Bull I have been patiently waiting for a bull market to begin in Biogen Inc (NASDAQ:BIIB) stock. I got my hopes up after the United States presidential election results revealed that Donald Trump was the victor, and BIIB stock—and the entire biotech sector—surged in…

What Happened to CEMP Stock? Cempra Inc (NASDAQ:CEMP) fell 56% by Thursday afternoon after Cempra's new drug application for its pneumonia medicine was rejected by the U.S. Food and Drug Administration (FDA). The news of the rejection of Solithromycin, an oral and intravenous pneumonia treatment, sent CEMP stock…

CELG Stock: Chart-astic! I have found that it is always best to focus on investments that abide by technical rules and to try to avoid those that do not. Celgene Corporation (NASDAQ:CELG) stock is one of those investments that abides to technical indicators and patterns to such a…

GILD Stock: Potentially Bullish? It has been quite a disappointing year for Gilead Sciences, Inc. (NASDAQ:GILD) stock, as its performance year-to-date is -25%. This performance is not surprising, and I have outlined numerous times in my previous reports why I am bearish on Gilead stock . My bearish views are…

What Killed Alexion Stock Today?  Alexion stock (Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)) dropped over 13% by midday on Monday as the company's CEO and CFO resigned, a month after the company began investigating allegations related to sales practices of its prized blood disorder drug "Soliris." Alexion stock joins the fast-growing throng…

CARA Stock: Bullish Tailwinds Cara Therapeutics Inc (NASDAQ:CARA) stock has caught my eye for a number of reasons. The price chart is compelling and constructive, and the company is delving into the medical marijuana sector. What more can anyone ask for in the smoking-hot stock market? Marijuana stocks…

BLUE Stock: Breakaway Gap bluebird bio Inc (NASDAQ:BLUE) stock is trading higher on the good news that was disseminated after the close of trading on November 30. The news is actually better than good; it's fantastic. The company's myeloma cancer treatment has delivered significant benefits with no major side…

Valeant Pharmaceuticals Intl Inc (NYSE:VRX, TSE:VRX) just cannot catch a break these days. VRX stock is down another 7.5% as a deal to sell off its stomach medication fell through. Japan’s Takeda Pharmaceutical Co Ltd (TYO:4502) was in talks with Valeant to acquire Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) from the company…

BIIB Stock: Unexpected Sell-Off Biogen Inc (NASDAQ:BIIB) stock is down 5.91% on the back of news surrounding a clinical drug failure from one of its competitors, Eli Lilly and Co (NYSE:LLY). Even though this news is not directly related to Biogen Inc, investors in BIIB stock fear that that…

VRX Stock: Bottom Fishing Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock made headlines last week when it reported its earnings and, to the dismay of the bulls, earnings were disappointing as Valeant missed on both the top and bottom lines. Valeant management guided lower as they now expect total…

REGN Stock: Bullish Biotechs Donald Trump's election victory sent biotech stocks screaming higher as the iShares NASDAQ Biotechnology ETF (NASDAQ:IBB), which acts as a proxy for this sector, was up 7.44% on Wednesday morning. This reaction to the election is a classic example of "sell on the rumor,…